TR200301378T3 - Pikolinik asit, fusarik asit ve bunların türevlerini ihtiva eden farmakolojik madde - Google Patents

Pikolinik asit, fusarik asit ve bunların türevlerini ihtiva eden farmakolojik madde

Info

Publication number
TR200301378T3
TR200301378T3 TR2003/01378T TR200301378T TR200301378T3 TR 200301378 T3 TR200301378 T3 TR 200301378T3 TR 2003/01378 T TR2003/01378 T TR 2003/01378T TR 200301378 T TR200301378 T TR 200301378T TR 200301378 T3 TR200301378 T3 TR 200301378T3
Authority
TR
Turkey
Prior art keywords
inflammatory
derivatives
diseases
acid
preparations
Prior art date
Application number
TR2003/01378T
Other languages
English (en)
Turkish (tr)
Inventor
Jose A. Fernandez-Pol
N. Amin Avinash
G. Douglas Michael
Original Assignee
Novactyl, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novactyl, Inc. filed Critical Novactyl, Inc.
Publication of TR200301378T3 publication Critical patent/TR200301378T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
TR2003/01378T 2000-02-15 2001-02-15 Pikolinik asit, fusarik asit ve bunların türevlerini ihtiva eden farmakolojik madde TR200301378T3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18260800P 2000-02-15 2000-02-15

Publications (1)

Publication Number Publication Date
TR200301378T3 true TR200301378T3 (tr) 2003-12-22

Family

ID=22669217

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/01378T TR200301378T3 (tr) 2000-02-15 2001-02-15 Pikolinik asit, fusarik asit ve bunların türevlerini ihtiva eden farmakolojik madde

Country Status (10)

Country Link
US (1) US6403618B1 (cg-RX-API-DMAC7.html)
EP (1) EP1257262A2 (cg-RX-API-DMAC7.html)
JP (1) JP2003522786A (cg-RX-API-DMAC7.html)
AU (1) AU781066B2 (cg-RX-API-DMAC7.html)
BR (1) BR0108400A (cg-RX-API-DMAC7.html)
DE (1) DE01909253T1 (cg-RX-API-DMAC7.html)
ES (1) ES2215493T1 (cg-RX-API-DMAC7.html)
MX (1) MXPA02007954A (cg-RX-API-DMAC7.html)
TR (1) TR200301378T3 (cg-RX-API-DMAC7.html)
WO (1) WO2001060349A2 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060074063A1 (en) * 1995-12-29 2006-04-06 Fernandez-Pol Jose A Pharmacological agent and method of treatment
US6579891B1 (en) * 1995-12-29 2003-06-17 Novactyl, Inc. Agent and method for prevention and treatment of cancer in animals
CA2456269A1 (en) * 2001-08-23 2003-03-06 The Government Of The United States Of America Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives
AU2002367087A1 (en) * 2001-12-21 2003-07-15 7Tm Pharma A/S Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
CN101134119A (zh) * 2002-05-24 2008-03-05 血管技术国际股份公司 用于涂覆医用植入物的组合物和方法
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
US20050158356A1 (en) * 2003-11-20 2005-07-21 Angiotech International Ag Implantable sensors and implantable pumps and anti-scarring agents
CA2552607C (en) * 2004-01-07 2012-04-17 E-L Management Corporation Cosmetic composition and method for retarding hair growth
US20050239723A1 (en) * 2004-04-27 2005-10-27 Amin Avinash N Compositions and methods useful for treatment of acne
US20070178062A1 (en) * 2005-10-07 2007-08-02 Nathan Ravi Treatment of presbyopia with picolinic acid and its analogs
JP2009512454A (ja) * 2005-10-20 2009-03-26 ビアメト ファーマシューティカルズ,インク. 金属タンパク質のメタル化経路のモジュレーターのスクリーニング方法
EP2482807A4 (en) 2009-10-02 2013-04-24 Brigham & Womens Hospital COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS OF CONTACT DERMATITIS
GB201317619D0 (en) 2013-10-04 2013-11-20 Uni I Oslo Compounds
WO2018022823A1 (en) * 2016-07-28 2018-02-01 Asieris Pharmaceutical Technologies Co., Ltd. Uses of dopamine beta-hydroxylase (dbh) inhibitors and serotonin receptor (5-ht) antagonists for the treatment of cancer
GB201613946D0 (en) 2016-08-15 2016-09-28 Univ Oslo Compounds
WO2026104587A1 (en) 2024-11-13 2026-05-21 Adjutec Pharma As Cyclic boronic acid esters useful as adjuvants in the treatment of bacterial infections

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903285A (en) 1972-12-29 1975-09-02 Microbial Chem Res Found Method for treating parkinsonism
CH629488A5 (en) 1975-11-28 1982-04-30 Scherico Ltd Processes for preparing novel picolinic acid derivatives.
ZA767103B (en) 1975-11-28 1977-10-26 Scherico Ltd Picolinic acid derivatives and processes for their preparation
US4044140A (en) 1975-11-28 1977-08-23 Schering Corporation Trityl picolinic acid derivatives and their use as anti-acne agents
US4120762A (en) 1977-09-30 1978-10-17 Alden Research Foundation Electrochemical recording medium
US4293547A (en) 1980-08-25 1981-10-06 The Upjohn Company Method of treating malaria
US4443459A (en) 1981-05-26 1984-04-17 Banyu Pharmaceutical Co., Ltd. α-Tocopheryl ester of 5-substituted picolinic acid and hypotensive composition containing it
US4814351A (en) 1987-06-26 1989-03-21 Redken Laboratories, Inc. Scalp treatment
US5536743A (en) 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
US5057320A (en) 1988-08-01 1991-10-15 Nutrition 21 Means and method for increasing skin respiration
US5157046A (en) 1988-11-29 1992-10-20 Janssen Pharmaceutica N.V. Method of treating epithelial disorders
US5219847A (en) 1989-06-12 1993-06-15 Shiseido Company, Ltd. Antipruritic composition
FR2657259A1 (fr) 1990-01-25 1991-07-26 Adir Utilisation de la n-myristoyl-(s)-phenylalanine pour l'obtention de medicaments destines au traitement des maladies faisant intervenir la myristoylation.
US5484951A (en) 1990-10-19 1996-01-16 Octamer, Incorporated 5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
US5391537A (en) 1990-10-25 1995-02-21 Kumiai Chemical Industry Co., Ltd. Picolinic acid derivative, and herbicidal composition
US5403816A (en) 1990-10-25 1995-04-04 Kumiai Chemical Industry Co., Ltd. Picolinic acid derivative and herbicidal composition
US5173486A (en) 1991-08-26 1992-12-22 Bristol-Myers Squibb Company Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents
US5516941A (en) 1991-10-22 1996-05-14 Octamer, Inc. Specific inactivators of "retroviral" (asymmetric) zinc fingers
IL104323A0 (en) 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
US5284840A (en) 1992-06-12 1994-02-08 Merck & Co., Inc. Alkylidene macrolides having immunosuppressive activity
US5962463A (en) * 1992-10-09 1999-10-05 Massachusetts Institute Of Technology Methods of stimulating non-amyloidogenic processing of the amyloid precursor protein
AU7044994A (en) 1993-05-24 1994-12-20 Nycomed Pharma Hemoregulatory peptides
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
FR2736263B1 (fr) 1995-07-07 1997-09-26 C3D Sarl Composition dermocosmetique depigmentante et son utilisation
US5767135A (en) 1995-12-29 1998-06-16 Fernandez-Pol; Jose Alberto Antiviral agent
JP3337992B2 (ja) 1997-11-04 2002-10-28 ファイザー製薬株式会社 5−置換ピコリン酸化合物及びその製造方法

Also Published As

Publication number Publication date
EP1257262A2 (en) 2002-11-20
MXPA02007954A (es) 2004-09-10
DE01909253T1 (de) 2004-04-15
JP2003522786A (ja) 2003-07-29
US6403618B1 (en) 2002-06-11
AU781066B2 (en) 2005-05-05
AU3702801A (en) 2001-08-27
BR0108400A (pt) 2003-03-11
WO2001060349A3 (en) 2001-11-08
WO2001060349A2 (en) 2001-08-23
WO2001060349B1 (en) 2001-12-27
ES2215493T1 (es) 2004-10-16

Similar Documents

Publication Publication Date Title
ATE310518T1 (de) Antivirale verbindung
WO2002020486A3 (en) Picolinic acid derivatives for the prevention and treatment of cancer in animals
EA200100772A1 (ru) Бензогетероциклы и их применение в качестве мек ингибиторов
DK1438481T3 (da) Behandlingspræparat
MXPA02007954A (es) Agente farmacologico que comprende acido-picolinico, acido furasico y sus derivados.
DK1443915T3 (da) Farmaceutiske og kosmetiske præparater indeholdende aromatiske aldehyder, der bærer en oxygruppe
NO20030748L (no) Prodruger av betulinsyrederivater for behandlingen av kreft og HIV
DE60011100D1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen
ATE430573T1 (de) Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen
TR200101307T2 (tr) Antranilik asit amidler ve ilaç olarak kullanılmaları.
AU3134495A (en) Vascular treatment method and apparatus
TR200201246T2 (tr) Hidroksieikosatetraenoik asit türevlerini ihtiva eden bileşimler ve göz kuruması bozukluklarının iyileştirilmesinde kullanım yöntemleri
ATE410159T1 (de) Fulvinsäure und deren verwendung in der behandlung von candida infektionen
PT1115701E (pt) Ureias de arilsulfonanilida
NO20033883D0 (no) Heterosykliske derivater for behandling av kreft og andre proliferative sykdommer
DE50312034D1 (de) Liposomale glucocorticoide
EE200200625A (et) Orto-asendatud antraniilhappeamiidid ja nende kasutamine ravimitena
ITMI20000383A0 (it) Coniugati di acidi biliari con chelati complessi di ioni metallici e loro uso
BR9911060A (pt) Composições compreendendo mono- ou dinitrato orgânico para tratar impotência
EA200300934A1 (ru) Агенты и способы, предназначенные для лечения опухолевых заболеваний
EP1608623A4 (en) METALIONIC RADIATORS AND THEIR THERAPEUTIC USE
MXPA02011858A (es) Inhibidores de adhesion de celula mediada por alfabeta2.
GB0003025D0 (en) Novel compounds
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
DE60108626D1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b] pyridinen als cyclin-abhängige kinase-hemmer